Article Details

Specialised Therapeutics signs exclusive license agreement with CanariaBio for new ...

Retrieved on: 2023-10-12 19:03:43

Tags for this article:

Click the tags to see associated articles and topics

Specialised Therapeutics signs exclusive license agreement with CanariaBio for new .... View article details on hiswai:

Excerpt

... antibodies targeting CA-125, MUC1, PSA, and HER2/neu. About Oregovomab. Oregovomab is a murine monoclonal antibody directed to the tumor-associated ...

Article found on: en.prnasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up